Circulating thrombotic and haemostatic components in patients with coronary artery disease.

about

Comparison Between Serum hsCRP and LDL Cholesterol for Search of a Better Predictor for Ischemic Heart Disease Circulating Thrombotic Risk Factors in Young Patients with Coronary Artery Disease Who Are on Statins and Anti-platelet Drugs.

P2860

Q35022399-105363B1-0523-4B47-8CCF-59FD653560A0 Q37013011-6A201600-14DE-47EF-8791-6E70C2059C41

P2860

Circulating thrombotic and haemostatic components in patients with coronary artery disease.

Item

http://www.wikidata.org/entity/Q36262859

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Circulating thrombotic and hae ...... with coronary artery disease.

@ast

Circulating thrombotic and hae ...... with coronary artery disease.

@en

type

Item

label

Circulating thrombotic and hae ...... with coronary artery disease.

@ast

Circulating thrombotic and hae ...... with coronary artery disease.

@en

prefLabel

Circulating thrombotic and hae ...... with coronary artery disease.

@ast

Circulating thrombotic and hae ...... with coronary artery disease.

@en

P1476

Circulating thrombotic and hae ...... with coronary artery disease.

@en

P2093

A Abraham

http://www.w3.org/2001/XMLSchema#string

A P Walvalkar

http://www.w3.org/2001/XMLSchema#string

J B Vasvani

http://www.w3.org/2001/XMLSchema#string

K V Kudalkar

http://www.w3.org/2001/XMLSchema#string

Kavita K Shalia

http://www.w3.org/2001/XMLSchema#string

M R Mashru

http://www.w3.org/2001/XMLSchema#string

P K Thakur

http://www.w3.org/2001/XMLSchema#string

R A Mokal

http://www.w3.org/2001/XMLSchema#string

S L Soneji

http://www.w3.org/2001/XMLSchema#string

S M Mithbawkar

http://www.w3.org/2001/XMLSchema#string

P2860

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression

Tissue factor pathway inhibitor (TFPI)--an update.

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects.

Blood-borne tissue factor: another view of thrombosis

Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principle.

Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.

Relationship between tissue type plasminogen activator and coronary vulnerable plaque in patients with acute coronary syndrome: virtual histological study.

P2888

s12291-010-0005-2

P304

20-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12291-010-0005-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232722271

http://www.w3.org/2001/XMLSchema#string

P698

23105879

http://www.w3.org/2001/XMLSchema#string

P932

3453008

http://www.w3.org/2001/XMLSchema#string

Circulating thrombotic and haemostatic components in patients with coronary artery disease.

about

P2860

P2860

Circulating thrombotic and haemostatic components in patients with coronary artery disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932